---
description: The current system of clinical research is too slow, expensive, and imprecise.
---

# â˜  Problems We Seek To Address

#### &#x20;The Cost of Clinical Research

* It costs [$2.6 billion](https://www.semanticscholar.org/paper/Innovation-in-the-pharmaceutical-industry%3A-New-of-DiMasi-Grabowski/3275f31c072ac11c6ca7a5260bd535720f07df41) to bring a drug to market (including failed attempts).
* The process takes over 10 years.
* It costs [$36k](https://www.clinicalleader.com/doc/getting-a-handle-on-clinical-trial-costs-0001) per subject in Phase III clinical trials.

![clinical trial cost](../.gitbook/assets/cost-of-clinical-trials.png) [source: clinicalresearch.io](https://www.clinicalresearch.io/blog/industry-trends/cost-of-clinical-trials-breakdown/)

This high cost leads to the following problems:

{% content-ref url="../1-introduction-and-challenges/no-data-on-unpatentable-molecules.md" %}
[no-data-on-unpatentable-molecules.md](../1-introduction-and-challenges/no-data-on-unpatentable-molecules.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/lack-of-incentive-to-discover-the-full-range-of-applications-for-off-patent-treatments.md" %}
[lack-of-incentive-to-discover-the-full-range-of-applications-for-off-patent-treatments.md](../1-introduction-and-challenges/lack-of-incentive-to-discover-the-full-range-of-applications-for-off-patent-treatments.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/no-long-term-outcome-data.md" %}
[no-long-term-outcome-data.md](../1-introduction-and-challenges/no-long-term-outcome-data.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/conflicts-of-interest.md" %}
[conflicts-of-interest.md](../1-introduction-and-challenges/conflicts-of-interest.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/negative-results-are-never-published.md" %}
[negative-results-are-never-published.md](../1-introduction-and-challenges/negative-results-are-never-published.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/trials-often-arent-representative-of-real-patients.md" %}
[trials-often-arent-representative-of-real-patients.md](../1-introduction-and-challenges/trials-often-arent-representative-of-real-patients.md)
{% endcontent-ref %}

This work is licensed under a [Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License](http://creativecommons.org/licenses/by-nc-sa/4.0/).
